QIAGEN OmicSoft and Biomedical Knowledge Base
Supercharge your AI in drug discovery with high-quality biomedical data
66 views
Jesper Ryge (Idorsia Pharmaceuticals), Alex Jarasch (Neo4j) and Venkatesh Moktali (QIAGEN Digital Insights) come together to showcase the practical applications of high-quality biomedical relationships data from the QIAGEN Biomedical Knowledge Base (BKB) to accelerate, improve and transform research in drug discovery and pharmaceutical development. By applying AI to a gene-disease knowledge graph, they identify promising drug targets and key mechanisms underlying diseases. A brief introduction to Neo4j shows how graph-centric analysis and visualizations facilitate the effective exploration of large knowledge graphs like BKB. This integration of high-quality curated data, AI-driven analysis and advanced visualization provides valuable insights and accelerates the progress of precision medicine.
In this webinar, you’ll learn how you can:
Build disease interactomes using protein-protein interactions
Identify high-quality drug targets using inferred causal interactions
Choose targets with the least likelihood of adverse outcomes by leveraging the depth of the data in BKB
Formulate plausible hypotheses using state-of-the-art graph visualization
Don’t miss this chance to learn how to supercharge your AI toolbox to transform your drug discovery.
Related videos
QIAGEN OmicSoft and Biomedical Knowledge Base
QIAGEN Biomedical Knowledge Base: Data- and analytics-driven drug discovery
Biomedical relationships knowledge is now required for innovative data- and...
QIAGEN OmicSoft and Biomedical Knowledge Base
Biomarker discovery and disease pathology investigation using OmicSoft and Ingenuity Pathway...
In this training, attendees will learn how to harness curated ‘omics...
QIAGEN OmicSoft and Biomedical Knowledge Base
Drug treatment data investigation using Omicsoft and Ingenuity Pathway Analysis
In this training, the trainer will go over how to utilize public drug...
QIAGEN OmicSoft and Biomedical Knowledge Base
Exploring pan-cancer immunomodulators for biomarker discovery and validation using TCGA and...
Cancer outcome is influenced by both the tumor microenvironment and host...